Addition Therapeutics vs Palo Alto Networks

Side-by-side comparison of AI visibility scores, market position, and capabilities

Palo Alto Networks leads in AI visibility (84 vs 19)
Addition Therapeutics logo

Addition Therapeutics

EmergingBioTech

Non-Viral Gene Therapy (PRINT)

Emerged from stealth with $100M (Dec 2025) backed by Gates Foundation, SR One, Abingworth. PRINT LNP platform integrates RNA at specific genomic loci — potentially re-dosable gene therapy for rare and chronic diseases.

AI VisibilityBeta
Overall Score
D19
Category Rank
#1 of 1
AI Consensus
57%
Trend
up
Per Platform
ChatGPT
30
Perplexity
23
Gemini
11

About

Addition Therapeutics emerged from stealth in December 2025 with $100 million in financing backed by the Gates Foundation, SR One, and Abingworth, developing PRINT — a platform using lipid nanoparticles (LNPs) to deliver RNA and enzyme payloads that integrate therapeutic sequences at specific genomic loci. Unlike traditional AAV gene therapy (which requires viral vectors and can only be dosed once due to immune response), PRINT's non-viral approach is potentially re-dosable, opening gene therapy to chronic diseases beyond rare genetic disorders.

Full profile
Palo Alto Networks logo

Palo Alto Networks

LeaderSecurity

Network Security

Santa Clara cybersecurity platform (NASDAQ: PANW) $8.0B FY2024 revenue (+16%); platformization 3,600+ customers, Cortex XSIAM AI SOC, $4.2B NGSSAR +42%, competing with CrowdStrike and Microsoft Defender.

AI VisibilityBeta
Overall Score
A84
Category Rank
#1 of 1
AI Consensus
66%
Trend
down
Per Platform
ChatGPT
88
Perplexity
77
Gemini
92

About

Palo Alto Networks, Inc. is a Santa Clara, California-based cybersecurity platform company — publicly traded on the NASDAQ (NASDAQ: PANW) as an S&P 500 Information Technology component — providing network security, cloud security, and AI-driven security operations through three integrated security platforms: Strata (network security — next-generation firewalls, SD-WAN, Zero Trust Network Access), Prisma Cloud (cloud security posture management, cloud workload protection, CSPM/CWPP), and Cortex (AI-driven security operations — XSIAM extended security intelligence and automation management, XDR endpoint detection and response, XSOAR security orchestration) through approximately 15,000 employees worldwide. In fiscal year 2024 (ending July 2024), Palo Alto Networks reported revenues of $8.0 billion (+16% year-over-year), with next-generation security Annual Recurring Revenue (ARR — Prisma Cloud and Cortex subscriptions) growing 42% to $4.2 billion as large enterprise and government customers consolidated security toolsets onto Palo Alto Networks' platform versus maintaining dozens of point solution security vendors. CEO Nikesh Arora (joined 2018 from SoftBank as Chairman and CEO) has executed the "platformization" strategy — convincing large enterprise security buyers to replace 10-15 individual security vendors (email security, endpoint protection, cloud workload protection, network detection) with a consolidated Palo Alto Networks platform contract that provides 80% of point-solution capabilities at 50% of the total cost — using the first-year transition economics to accelerate platform adoption through deferred commitment offers (paying a lower platform price in year 1 in exchange for multi-year platform commitment in years 2-4).

Full profile

AI Visibility Head-to-Head

19
Overall Score
84
#1
Category Rank
#1
57
AI Consensus
66
up
Trend
down
30
ChatGPT
88
23
Perplexity
77
11
Gemini
92
21
Claude
87
17
Grok
89

Capabilities & Ecosystem

Capabilities

Only Addition Therapeutics
Non-Viral Gene Therapy (PRINT)
Only Palo Alto Networks
Network Security

Integrations

Only Palo Alto Networks
Palo Alto Networks is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.